The Department does not hold figures on the cost of providing drugs for cancer patients. However, it completed a tracking investment exercise in 2005, which showed that an additional £192 million was spent on cancer drugs in the three years to 2003-04, which equates to over £60 million new investment per year. More generally, £3.4 billion was spent on cancer services in 2003-04 and this increased to around £3.8 billion in 2004-05.